Medical Xpress - Cardiology
NOVEMBER 14, 2024
Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns. Fortunately, this attention to cholesterol has prompted the development of cholesterol-lowering drugs called statins and lifestyle interventions like dietary and exercise regimens.
Science Daily - Heart Disease
NOVEMBER 11, 2024
Fear of another heart attack was a significant ongoing contributor to how heart attack survivors perceive their health, according to a study. While anxiety and depression are recognized as common conditions after a heart attack, they did not explain the impact of fear of recurrence in this study. The researchers suggest that fear of another heart attack should be evaluated and addressed separately from depression and anxiety.
Dr. Paddy Barrett
NOVEMBER 12, 2024
Let me tell you a story. At least once a week, one of my friends or someone I know will contact me with the same question: “I am getting to that age where heart disease is a possibility. What do I need to do?” After getting tired of writing long emails, I started thinking I should put together a presentation they could watch. This would at least prevent me from going over the same topic over and over again.
ECG Cases
NOVEMBER 12, 2024
In this EM Cases main episode podcast, we tackle the complexities of trauma airway management, including direct trauma to the airway. We discuss indications and timing of intubation, penetrating neck trauma, the head injured patient, the agitated patients and the soiled airway. The critical question is: when should we deviate from, delay or modify RSI, and how do we navigate the unique challenges presented by trauma airways and airway trauma?
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Medical Xpress - Cardiology
NOVEMBER 14, 2024
A research team from the Nagoya University Graduate School of Medicine has discovered a promising way to slow the progression of heart failure in mice. They fed mice a diet rich in the soybean protein, β-conglycinin (β-CG), which can support heart health by influencing gut bacteria. Their analysis revealed that the soybean protein rich diet increased the production of the short-chain fatty acids (SCFAs) in the intestine that play a role in protecting the heart.
Frontiers in Cardiovascular Medicine
NOVEMBER 14, 2024
BackgroundIn recent years, the relationship between periodontal disease (PD) and atherosclerosis (AS) has garnered significant scholarly attention. Chronic inflammation induced by PD may promote the onset and progression of AS through multiple mechanisms. Given the increasing global incidence of both PD and AS, which adversely affects patients’ quality of life and longevity, further investigation into the interplay between PD and AS is of substantial clinical importance.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
CardiacWire
NOVEMBER 13, 2024
Troubling results from the SAFE-IVC study revealed that just one in six patients gets their inferior vena cava filters removed, despite clear guidelines calling for IVC filter removal as early as possible. An IVC filter is a small device that helps stop blood clots from going up into the lungs and is usually surgically inserted. IVC filters are used to prevent pulmonary embolism in patients with venous thromboembolism and can’t receive anticoagulation treatment.
MIBHS
NOVEMBER 15, 2024
Undergoing heart surgery can be a life-changing experience, especially for those with coronary artery disease or other heart conditions. Minimally invasive or bloodless heart surgery techniques have made recovery more manageable and less daunting. However, as patients emerge from this journey, many are eager to return to their normal activities, including running.
Frontiers in Cardiovascular Medicine
NOVEMBER 12, 2024
ObjectiveThis study aimed to investigate the causal relationship between insomnia and the risk of myocardial infarction (MI) and explore potential mediators such as smoking initiation, alcohol consumption and body mass index (BMI) using mendelian randomization (MR) analysis.MethodsData from 1,207,228 individuals of European ancestry were obtained from the UK Biobank and 23andMe for insomnia-related genetic associations.
American Heart News - Heart News
NOVEMBER 13, 2024
Statement Highlights: A new scientific statement outlines the role of primary care professionals in helping their patients achieve Life's Essential 8, the key measures for improving and maintaining cardiovascular health defined by the American Heart.
CardiacWire
NOVEMBER 15, 2024
Eli Lilly’s GLP-1 tirzepatide has triumphed yet again, as the full SURMOUNT-1 trial showed that the drug kept nearly 99% of prediabetic patients diabetes-free over 3 years, while improving cardiometabolic metrics. Tirzepatide (Mounjaro / Zepbound) is used to promote weight loss and treat Type 2 diabetes through the GIP and GLP-1 receptor pathways. Like Novo Nordisk’s semaglutide, evidence of tirzepatide’s cardiometabolic and cardiovascular benefits continue to mount.
Becker's Hospital Review - Cardiology
NOVEMBER 11, 2024
Cleveland Clinic, Chesterfield, Mo.-based Mercy and Bentonville, Ark.-based nonprofit organizations the Alice L. Walton Foundation and the Heartland Whole Health Institute have partnered to invest $700 million over 30 years to address the "$950 million lost annually" as patients leave Northwest Arkansas for specialty care, according to a Sept. 24 news release shared by Cleveland Clinic.
Frontiers in Cardiovascular Medicine
NOVEMBER 11, 2024
AimTo evaluate the real-life effectiveness and safety of hydrogen inhalation (HI) therapy as an additional treatment in Chinese adults with hypertension.MethodsThis observational, retrospective clinical study included hypertensive patients receiving routine antihypertensives with or without HI initiation from 2018 to 2023. Participants were assigned to the HI group or non-HI group (control group) after propensity score matching.
GEMMS
NOVEMBER 11, 2024
As the healthcare landscape evolves, many cardiology practices shift from the traditional fee-for-service (FFS) model to value-based care. This transition reflects a growing focus on prioritizing patient outcomes over the volume of services provided. By emphasizing healthcare efficiency and improved outcomes, value-based care is transforming the way cardiology practices deliver patient care, especially when addressing chronic conditions common in cardiac patients.
American Heart News - Heart News
NOVEMBER 11, 2024
Research Highlights: A preliminary study combining a patent-applied, AI-powered algorithm with a high-speed, 5-to 30-second video of skin on the face and the palm of the hand detected if someone had high blood pressure as well as using a blood.
DAIC
NOVEMBER 13, 2024
tim.hodson Wed, 11/13/2024 - 14:27 Nov. 13, 2024 – A recent study has demonstrated the value of the single-exposure dual-energy X-ray detector in advancing cardiovascular risk assessment. Published in the Canadian Association of Radiologists Journal, the paper, “ Opportunistic Identification of Coronary Artery Calcium and Valve/Vascular Calcifications on Chest X-ray: Improvement with Single-Exposure Dual-Energy Imaging ,” establishes the potential of single-exposure dual-energy imaging in dete
Frontiers in Cardiovascular Medicine
NOVEMBER 14, 2024
BackgroundCoronary heart disease is a common cardiovascular disease, yferroptosiset its relationship with iron metabolism remains unclear.MethodsGene expression data from peripheral blood samples of patients with coronary heart disease and a healthy control group were utilized for a comprehensive analysis that included differential expression analysis, weighted gene co-expression network analysis, gene enrichment analysis, and the development of a logistic regression model to investigate the ass
HCPLive
NOVEMBER 15, 2024
IL-18 levels were consistently lower across participants with different SARDs, remission status, and COVID-19 disease characteristics.
Med Page Today
NOVEMBER 13, 2024
(MedPage Today) -- The world endured its hottest summer on record in 2024, and the transition to fall brought devastation from multiple hurricanes in the U.S. The growing effects of climate change are widespread and becoming more severe. Now, new.
Nature Reviews - Cardiology
NOVEMBER 14, 2024
Nature Reviews Cardiology, Published online: 15 November 2024; doi:10.1038/s41569-024-01098-8 Cell therapy has emerged in the past 20 years as a promising avenue for cardiac repair and regeneration. In this Review, Zhang and colleagues provide an overview of the evolution of cell-based and cell product-based therapies for the treatment of heart failure, including challenges and lessons learned, and summarize ongoing clinical trials on the feasibility of novel or underexplored treatment protocols
Frontiers in Cardiovascular Medicine
NOVEMBER 12, 2024
ObjectiveTo investigate the effect of low-dose rivaroxaban on bleeding events in low-weight patients with nonvalvular atrial fibrillation.MethodsA retrospective study was conducted in patients with nonvalvular atrial fibrillation (weight ≤ 60 kg) who were admitted to the Department of Cardiology of Jiangxi Provincial People's Hospital from June 1, 2022, to December 12, 2022 and received anticoagulant therapy with rivaroxaban.
HCPLive
NOVEMBER 14, 2024
In this episode, hosts discuss the latest developments in GLP-1 receptor agonists, with a particular focus on semaglutide.
Med Page Today
NOVEMBER 13, 2024
(MedPage Today) -- Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study suggested. Among more than 200,000 individuals with AUD, those taking semaglutide (Ozempic, Wegovy) had.
Dr. Smith's ECG Blog
NOVEMBER 11, 2024
Written by Willy Frick A middle aged man presented for elective outpatient surgery. The following ECG was obtained in the preoperative area. What do you think? The ECG shows sinus rhythm with a rate of about 78 and 2:1 AV conduction along with right bundle branch block and left anterior fascicular block. The PR interval on the conducted beats is prolonged, about 220 ms.
Frontiers in Cardiovascular Medicine
NOVEMBER 12, 2024
BackgroundVitamin B1 deficiency is closely associated with vascular system damage, but the relationship between dietary vitamin B1 intake and abdominal aortic calcification (AAC) remains unclear and warrants further investigation.Methods2,640 participants from the National Health and Nutrition Examination Survey (NHANES) 2013–2014 were included in the study.
Science Daily - Heart Disease
NOVEMBER 11, 2024
All patients who have had a heart attack are typically treated using beta blockers. According to a recent study, this drug is unlikely to be needed for those heart patients who have a normal pumping ability. Now a sub-study shows that there is also a risk that these patients will become depressed by the treatment.
American Heart News - Heart News
NOVEMBER 11, 2024
Research Highlights: A study of older adults in Australia and the U.S. indicates that cholesterol levels that fluctuate significantly from year to year without a change in medication may someday help to identify those with a higher risk of developing.
HCPLive
NOVEMBER 10, 2024
Research presented at NASPGHAN 2024 found most children with chronic hepatitis C had neurodevelopmental disorders, highlighting the need for proactive care.
Frontiers in Cardiovascular Medicine
NOVEMBER 11, 2024
ObjectivesThis study aimed to investigate the association between the weight-adjusted waist index (WWI) and the prevalence of hypertension in U.S. adults.MethodsData were sourced from the National Health and Nutrition Examination Survey (NHANES) spanning 2005–2018. In our cross-sectional study, we focused on the non-institutional U.S. population over the age of 18 from various communities in the United States.
Science Daily - Heart Disease
NOVEMBER 14, 2024
Time spent sedentary beyond six hours per day during growth from childhood through young adulthood may cause an excess increase of 4 mmHg in systolic blood pressure, a new study shows. Continuously engaging in light physical activity (LPA) significantly mitigated the rise in blood pressure.
Dr. S. Venkatesan MD
NOVEMBER 13, 2024
A right answer to this MCQ will check , how realistically we have understood modern medical decision making.It could change the way we practice cardiology, provided you choose the right response. Which of the following correctly describe about the disease specific popular guidelines by various scientific committees like AHA, ESC, and other by global expert f orums ?
HCPLive
NOVEMBER 9, 2024
NASPGHAN 2024 data suggests children and adolescents with a history of COVID-19 were twice as likely to develop IBS during the follow-up period.
Frontiers in Cardiovascular Medicine
NOVEMBER 14, 2024
Cardiac myxoma is a common benign tumor, however, myxoma extensively distributed on the mitral valve is rare and seldom reported. A patient who presented with exertional dyspnea and chest tightness was examined by transthoracic and transesophageal echocardiography successively. Multiple neoplasms on the mitral valve with moderate mitral regurgitation were found and were further proved to be a diffuse myxoma on the mitral valve by histology.
Science Daily - Heart Disease
NOVEMBER 11, 2024
The sooner a lay rescuer (bystander) starts cardiopulmonary resuscitation (CPR) on a person having a cardiac arrest at home or in public, up to 10 minutes after the arrest, the better the chances of survival and brain protection, according to an analysis of nearly 200,000 out-of-hospital cardiac arrest cases in the U.S. from 2013 to 2022.
Med Page Today
NOVEMBER 11, 2024
(MedPage Today) -- A small panel of circulating biomarkers may reliably distinguish hypertrophic cardiomyopathy (HCM) from similar conditions that cause left ventricular hypertrophy (LVH), researchers found. From proteomic profiling of nearly.
HCPLive
NOVEMBER 12, 2024
Masri discussed the new phase 3 trial of Intellia’s NTLA-2001 or nex-z.
Expert insights. Personalized for you.
128 
Let's personalize your content